Real-time enrollment status for this malignant mesothelioma clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 4:04 PM UTC
| NCT Number | NCT06566079 |
| Recruiting Status | Recruiting |
| Condition | Malignant Mesothelioma |
| Phase | PHASE1 |
| Target Enrollment | 160 participants |
| Active Locations | 6 sites in the US |
| Sponsor | InSilico Medicine Hong Kong Limited |
| Last Updated on CT.gov | September 16, 2026 (3 weeks ago) |
As of October 12, 2026: Clinical trial NCT06566079 is currently recruiting participants. This phase1 study for malignant mesothelioma is actively seeking new participants at 6 locations across the United States. The study is sponsored by InSilico Medicine Hong Kong Limited. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06566079 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 6 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06566079 was last updated 3 weeks ago (September 16, 2026). HelloStudys verifies this status automatically.